Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 06-2016 | 06-2015 | 12-2014 | 06-2014 | |
| Sales | 0 | 75 | 75 | 0 | 100 |
| Gross Profit | N/A | 75 | 75 | 0 | 100 |
| Operating Expenses | 9,840 | 11,270 | 18,152 | 13,583 | 9,248 |
| Operating Income | -9,840 | -11,195 | -18,077 | -13,583 | -9,148 |
| Interest Expense | 0 | 1 | 3 | 0 | 77 |
| Other Income | -7 | 2,248 | 16 | 16 | 0 |
| Pre-tax Income | -9,847 | -8,948 | -18,064 | -13,568 | -9,225 |
| Income Tax | N/A | -680 | N/A | 0 | N/A |
| Net Income Continuous | -9,847 | -8,268 | -18,064 | -11,958 | -9,225 |
| Net Income | $-9,847 | $-8,268 | $-18,064 | $-18,064 | $-9,225 |
| EPS Basic Total Ops | -104.00 | -16.80 | -52.40 | N/A | -2,024.00 |
| EPS Basic Continuous Ops | -93.67 | -16.27 | -50.12 | N/A | -1,347.49 |
| EPS Diluted Total Ops | -104.00 | -16.80 | -52.40 | N/A | -2,024.00 |
| EPS Diluted Continuous Ops | -93.67 | -16.27 | -50.12 | N/A | -1,347.49 |
| EBITDA(a) | $-9,832 | $-11,102 | $-17,900 | $-13,483 | $-8,798 |